Opthea Ltd (OPT)
Healthcare
Biotechnology
3.40 $
+7.2%
vs. previous close
Closing price · As of: 2. Jul 2026
Opthea Ltd (OPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2024), "Operating Cash Flow" came in at -161 million AUD. Tick rows to compare them in a chart.
All figures in millions of AUD.
| Tick rows to compare them in a chart (up to 4) | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.6 | -4.2 | -5.0 | -3.7 | -6.0 | -20 | -24 | -8.2 | -61 | -98 | -179 | -161 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | |
| – | – | – | – | – | – | 0.7 | 0.7 | 3.9 | 5.3 | 5.8 | 5.1 | |
| – | – | – | – | 0.4 | -8.8 | -1.9 | 7.6 | 16 | 6.7 | 7.9 | – | |
| – | – | – | -0.3 | -0.3 | 5.7 | -1.4 | 0.1 | -22 | 20 | 21 | 17 | |
| 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.2 | 0.3 | 0.0 | -0.2 | 0.2 | 0.0 | 0.3 | 0.5 | 0.9 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | 0.0 | – | – | – | – | – | – | – | |
| – | – | -1.4 | – | -2.4 | – | – | – | – | – | – | – | |
| – | – | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | -0.1 | 84 | – | |
| 0.5 | 0.0 | 12 | 0.0 | 43 | 0.5 | 13 | 48 | 157 | 0.2 | 249 | 244 | |
| -5.0 | -3.6 | 14 | 0.7 | 37 | -19 | -11 | 40 | 95 | -93 | 69 | 83 | |
| -5.6 | -4.3 | -5.0 | -3.7 | -6.0 | -20 | -24 | -8.2 | -61 | -98 | -179 | -161 |
Data as of: July 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.